A detailed history of Baxter Bros Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Baxter Bros Inc holds 28,030 shares of TMO stock, worth $14.8 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares
28,030
Previous 28,548 1.81%
Holding current value
$14.8 Million
Previous $15.8 Million 9.82%
% of portfolio
2.28%
Previous 2.08%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$531.86 - $624.21 $275,503 - $323,340
-518 Reduced 1.81%
28,030 $17.3 Million
Q2 2024

Jul 15, 2024

SELL
$541.52 - $599.02 $322,204 - $356,416
-595 Reduced 2.04%
28,548 $15.8 Million
Q1 2024

Apr 26, 2024

SELL
$528.82 - $599.43 $46,536 - $52,749
-88 Reduced 0.3%
29,143 $16.9 Million
Q4 2023

May 17, 2024

BUY
$431.41 - $532.94 $37,964 - $46,898
88 Added 0.3%
29,231 $15.5 Million
Q4 2023

Feb 06, 2024

SELL
$431.41 - $532.94 $81,536 - $100,725
-189 Reduced 0.64%
29,231 $15.5 Million
Q3 2023

May 17, 2024

BUY
$498.29 - $574.41 $120,586 - $139,007
242 Added 0.83%
29,385 $14.9 Million
Q3 2023

Oct 23, 2023

BUY
$498.29 - $574.41 $498 - $574
1 Added 0.0%
29,420 $14.9 Million
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $66,099 - $76,846
-130 Reduced 0.44%
29,419 $15.3 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $470,800 - $532,241
-880 Reduced 2.89%
29,549 $17 Million
Q4 2022

Jan 31, 2023

SELL
$484.71 - $571.37 $509,914 - $601,081
-1,052 Reduced 3.34%
30,429 $16.8 Million
Q3 2022

Nov 10, 2022

SELL
$507.19 - $604.49 $190,196 - $226,683
-375 Reduced 1.18%
31,481 $16 Million
Q2 2022

Jul 25, 2022

BUY
$500.9 - $612.21 $25,545 - $31,222
51 Added 0.16%
31,856 $17.3 Million
Q1 2022

Apr 20, 2022

SELL
$524.0 - $644.92 $215,888 - $265,707
-412 Reduced 1.28%
31,805 $18.8 Million
Q4 2021

Jan 14, 2022

SELL
$569.0 - $667.24 $82,505 - $96,749
-145 Reduced 0.45%
32,217 $21.5 Million
Q3 2021

Oct 25, 2021

SELL
$509.53 - $609.78 $420,871 - $503,678
-826 Reduced 2.49%
32,362 $18.5 Million
Q2 2021

Aug 11, 2021

SELL
$441.0 - $508.24 $8,379 - $9,656
-19 Reduced 0.06%
33,188 $16.7 Million
Q1 2021

Apr 23, 2021

SELL
$439.85 - $518.83 $293,819 - $346,578
-668 Reduced 1.97%
33,207 $15.2 Million
Q4 2020

Jan 25, 2021

BUY
$435.06 - $527.66 $63,083 - $76,510
145 Added 0.43%
33,875 $15.8 Million
Q3 2020

Nov 05, 2020

SELL
$359.77 - $441.52 $510,513 - $626,516
-1,419 Reduced 4.04%
33,730 $14.9 Million
Q2 2020

Jul 31, 2020

BUY
$275.2 - $362.34 $396,288 - $521,769
1,440 Added 4.27%
35,149 $12.7 Million
Q1 2020

Apr 17, 2020

BUY
$255.3 - $340.05 $709,734 - $945,339
2,780 Added 8.99%
33,709 $9.56 Million
Q4 2019

Jan 10, 2020

BUY
$271.93 - $328.04 $5.53 Million - $6.67 Million
20,325 Added 191.67%
30,929 $10 Million
Q4 2019

Jan 09, 2020

SELL
$271.93 - $328.04 $4.98 Million - $6 Million
-18,301 Reduced 63.31%
10,604 $1.33 Million
Q3 2019

Oct 21, 2019

SELL
$268.46 - $305.43 $305,775 - $347,884
-1,139 Reduced 3.79%
28,905 $8.42 Million
Q2 2019

Jul 29, 2019

BUY
$257.51 - $295.55 $114,334 - $131,224
444 Added 1.5%
30,044 $8.82 Million
Q1 2019

Apr 22, 2019

BUY
$212.17 - $273.72 $133,667 - $172,443
630 Added 2.17%
29,600 $8.1 Million
Q4 2018

Jan 22, 2019

BUY
$208.47 - $251.98 $75,257 - $90,964
361 Added 1.26%
28,970 $6.48 Million
Q3 2018

Oct 11, 2018

BUY
$205.57 - $244.32 $821,252 - $976,058
3,995 Added 16.23%
28,609 $6.98 Million
Q2 2018

Jul 17, 2018

BUY
$203.14 - $219.53 $410,139 - $443,231
2,019 Added 8.94%
24,614 $5.1 Million
Q1 2018

May 16, 2018

BUY
$192.98 - $224.11 $204,365 - $237,332
1,059 Added 4.92%
22,595 $4.67 Million
Q4 2017

Feb 01, 2018

BUY
$182.03 - $200.37 $172,200 - $189,550
946 Added 4.59%
21,536 $4.09 Million
Q3 2017

Oct 16, 2017

BUY
$171.74 - $194.04 $3.54 Million - $4 Million
20,590
20,590 $3.9 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Baxter Bros Inc Portfolio

Follow Baxter Bros Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.